OBJECTIVE: To evaluate the feasibility of non-invasive ventilation (NIV) through a new interface-the helmet-in the treatment of acute respiratory failure (ARF) in hematologic children. DESIGN AND SETTING: Observational, non-randomized report of four consecutive cases. Pediatric Intensive Care Unit in a university hospital. PATIENTS AND METHODS: Four consecutive females (aged 9-17 years) affected by acute leukemia (3 acute lymphocytic leukemia [ALL], 1 acute myeloid leukemia [AML]) and with hypoxemic ARF (defined by severe dyspnea at rest, respiratory rate >30 breaths/min, PaO2:FiO2 <200 and active contraction of the accessory muscles). Pressure support ventilation was delivered via a helmet (CaStar,Starmed, Italy) by means of an ICU ventilator (Servo 300, Siemens Elema, Sweden). RESULTS: We evaluated the effect of pressure support ventilation delivered by helmet on blood gases, respiratory rate, hemodynamics, patient tolerance, complication rate and outcome. An improvement of oxygenation was uniformly observed within the first 3 h after admission. The helmet was well tolerated by all children. No complication was observed. Two patients were discharged from the PICU in stable clinical conditions, whereas the remaining two children overcame the respiratory distress but had non-respiratory complications and eventually died. CONCLUSION: Non-invasive ventilation via the helmet can offer effective ventilatory support and improve gas exchange in the treatment of ARF in pediatric hematologic patients. As already shown in adults, NIV may decrease the risk of life-threatening complications associated with invasive mechanical ventilation (MV), also in children with hematologic malignancies; moreover, it offers the possibility of an earlier approach to respiratory failure in this patient subset.
OBJECTIVE: To evaluate the feasibility of non-invasive ventilation (NIV) through a new interface-the helmet-in the treatment of acute respiratory failure (ARF) in hematologic children. DESIGN AND SETTING: Observational, non-randomized report of four consecutive cases. Pediatric Intensive Care Unit in a university hospital. PATIENTS AND METHODS: Four consecutive females (aged 9-17 years) affected by acute leukemia (3 acute lymphocytic leukemia [ALL], 1 acute myeloid leukemia [AML]) and with hypoxemic ARF (defined by severe dyspnea at rest, respiratory rate >30 breaths/min, PaO2:FiO2 <200 and active contraction of the accessory muscles). Pressure support ventilation was delivered via a helmet (CaStar,Starmed, Italy) by means of an ICU ventilator (Servo 300, Siemens Elema, Sweden). RESULTS: We evaluated the effect of pressure support ventilation delivered by helmet on blood gases, respiratory rate, hemodynamics, patient tolerance, complication rate and outcome. An improvement of oxygenation was uniformly observed within the first 3 h after admission. The helmet was well tolerated by all children. No complication was observed. Two patients were discharged from the PICU in stable clinical conditions, whereas the remaining two children overcame the respiratory distress but had non-respiratory complications and eventually died. CONCLUSION: Non-invasive ventilation via the helmet can offer effective ventilatory support and improve gas exchange in the treatment of ARF in pediatric hematologic patients. As already shown in adults, NIV may decrease the risk of life-threatening complications associated with invasive mechanical ventilation (MV), also in children with hematologic malignancies; moreover, it offers the possibility of an earlier approach to respiratory failure in this patient subset.
Authors: M Antonelli; G Conti; M Rocco; M Bufi; R A De Blasi; G Vivino; A Gasparetto; G U Meduri Journal: N Engl J Med Date: 1998-08-13 Impact factor: 91.245
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2005-02-18 Impact factor: 17.440
Authors: Marco Piastra; Daniele De Luca; Laura Marzano; Eleonora Stival; Orazio Genovese; Domenico Pietrini; Giorgio Conti Journal: Intensive Care Med Date: 2011-07-14 Impact factor: 17.440
Authors: R Costa; P Navalesi; G Spinazzola; M Rossi; F Cavaliere; M Antonelli; R Proietti; G Conti Journal: Intensive Care Med Date: 2008-03-05 Impact factor: 17.440
Authors: Juan I Muñoz-Bonet; Eva M Flor-Macián; Patricia M Roselló; Mari C Llopis; Alicia Lizondo; José L López-Prats; Juan Brines Journal: World J Pediatr Date: 2010-06-12 Impact factor: 2.764
Authors: Juan Mayordomo-Colunga; Alberto Medina; Corsino Rey; Juan José Díaz; Andrés Concha; Marta Los Arcos; Sergio Menéndez Journal: Intensive Care Med Date: 2008-11-04 Impact factor: 17.440
Authors: Francesco Mojoli; Giorgio A Iotti; Maddalena Gerletti; Carlo Lucarini; Antonio Braschi Journal: Intensive Care Med Date: 2008-04-18 Impact factor: 17.440